SparingVision
Description: French biotech developing gene therapy for retinitis pigmentosa, a leading cause of blindness affecting 2M people globally.
Country: France
Based in: Paris
Founded: 2017
Funding Stage: Series A/B
Tags: ['biotech', 'medtech', 'Paris']
ACCESS DIRECTORY
Details about how we process your information are available in our Privacy Policy.
